DDX41: exploring the roles of a versatile helicase

被引：2
|
作者：
Winstone, Lacey [1 ]
Jung, Yohan [1 ]
Wu, Yuliang [1 ]
机构：
[1] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2024年 / 52卷 / 01期
基金：
加拿大自然科学与工程研究理事会;
关键词：
ACUTE MYELOID-LEUKEMIA; I IFN PRODUCTION; CYCLIC-DI-AMP; FUNCTIONAL-CHARACTERIZATION; R-LOOP; FAMILY; MUTATIONS; VARIANTS; SENSOR; EXPRESSION;
D O I：
10.1042/BST20230725
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
DDX41 is a DEAD-box helicase and is conserved across species. Mutations in DDX41 have been associated with myeloid neoplasms, including myelodysplastic syndrome and acute myeloid leukemia. Though its pathogenesis is not completely known, DDX41 has been shown to have many cellular roles, including in pre-mRNA splicing, innate immune sensing, ribosome biogenesis, translational regulation, and R -loop metabolism. In this review, we will summarize the latest understandings regarding the various roles of DDX41, as well as highlight challenges associated with drug development to target DDX41. Overall, understanding the molecular and cellular mechanisms of DDX41 could help develop novel therapeutic options for DDX41 mutation-related hematologic malignancies.
引用
收藏
页码：395 / 405
页数：11
相关论文
共 50 条
  • [1] The emerging roles of the DDX41 protein in immunity and diseases
    Jiang, Yan
    Zhu, Yanping
    Liu, Zhi-Jie
    Ouyang, Songying
    PROTEIN & CELL, 2017, 8 (02) : 83 - 89
  • [2] Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies
    Weinreb, Joshua T.
    Bowman, Teresa, V
    FEBS LETTERS, 2022, 596 (21) : 2736 - 2745
  • [3] Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis
    Shinriki, Satoru
    Matsui, Hirotaka
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Ribosome profiling analysis reveals the roles of DDX41 in translational regulation
    Tungalag, Saruul
    Shinriki, Satoru
    Hirayama, Mayumi
    Nagamachi, Akiko
    Kanai, Akinori
    Inaba, Toshiya
    Matsui, Hirotaka
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 876 - 888
  • [5] Current Understanding of DDX41 Mutations in Myeloid Neoplasms
    Kim, Kunhwa
    Ong, Faustine
    Sasaki, Koji
    CANCERS, 2023, 15 (02)
  • [6] DDX41: here, there ... and everywhere
    Reilly, Christopher R.
    Lane, Andrew A.
    BLOOD, 2023, 142 (14) : 1177 - 1178
  • [7] Ribosome profiling analysis reveals the roles of DDX41 in translational regulation
    Saruul Tungalag
    Satoru Shinriki
    Mayumi Hirayama
    Akiko Nagamachi
    Akinori Kanai
    Toshiya Inaba
    Hirotaka Matsui
    International Journal of Hematology, 2023, 117 : 876 - 888
  • [8] Myeloid neoplasms with germline DDX41 mutation
    Cheah, Jesse J. C.
    Hahn, Christopher N.
    Hiwase, Devendra K.
    Scott, Hamish S.
    Brown, Anna L.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (02) : 163 - 174
  • [9] High-Throughput Screening to Identify Inhibitors of DEAD Box Helicase DDX41
    Yoneyama-Hirozane, Mariko
    Kondo, Mitsuyo
    Matsumoto, Shin-ichi
    Morikawa-Oki, Akiko
    Morishita, Daisuke
    Nakanishi, Atsushi
    Kawamoto, Tomohiro
    Nakayama, Masaharu
    SLAS DISCOVERY, 2017, 22 (09) : 1084 - 1092
  • [10] DDX41 is required for cGAS-STING activation against DNA virus infection
    Singh, Ravi Shankar
    Vidhyasagar, Venkatasubramanian
    Yang, Shizhuo
    Arna, Ananna Bhadra
    Yadav, Manisha
    Aggarwal, Aanchal
    Aguilera, Alexya N.
    Shinriki, Satoru
    Bhanumathy, Kalpana Kalyanasundaram
    Pandey, Kannupriya
    Xu, Aizhang
    Rapin, Noreen
    Bosch, Mark
    DeCoteau, John
    Xiang, Jim
    Vizeacoumar, Franco J.
    Zhou, Yan
    Misra, Vikram
    Matsui, Hirotaka
    Ross, Susan R.
    Wu, Yuliang
    CELL REPORTS, 2022, 39 (08):
12345